Rules of myocardial revascularisation REVIVEed : Quantify”non-viable tissue” first.
December 20, 2023 by dr s venkatesan
”It looks like, science oftentimes struggles at the hands of scientists“
The weakest link in medical research is framing the right research question. How will you explain the drama of research on myocardial viability studies that have been going on full steam for more than 3 decades,? Which has become junk now.
This truth came out from a secondary analysis of the famous REVIVED-BCIS2 trial. For the busy guys, the conclusion is given in the box below.
JAMA Cardiol. 2023;8(12):1154-1161.


Final message
We realize, in the game of myocardial revascularisation the quantum of dead tissue determines the outcome of revascularization, not the amount of living tissues. This same question was asked & answered more than a decade ago (2009) on this site, of course without that damning evidence.
March 15, 2009 by dr s venkatesan
Many times, we don’t require large-scale RCTs, years of toil, and efforts wasting resources to prove an apparent sense of thinking.
Posted in Uncategorized | Tagged accc aha esc guid;ines on myocardial revascularisation, cabg, cabg patch study, ischemic dcm, myocardail viablity, pet scan for myocardial viablity, REVIVED BCIS2, viablity study myocardial |
- The Renal Warrior Project. Join Now
- Source: https://drsvenkatesan.com/2023/12/20/rules-of-myocardial-revascularisation-reviveed-very-late-quantifynon-viable-tissue-first/